Providence is adding oral/dental oncology facilities at Providence Portland and Providence St. Vincent Medical Centers.
Providence Cancer Center researchers have initiated several important clinical trials to investigate the effectiveness of promising new immunotherapies to treat patients with head and neck cancers.
Providence Oral, Head and Neck Cancer Clinics now serve patients at two locations: Providence Portland Medical Center and a newly opened clinic at Providence St. Vincent Medical Center.
Researchers at Providence Cancer Center received a $75,000 grant to study biomarkers that may help predict responses to immuntherapy and assist oncologists in making treatment-related decisions for patients with head and neck cancers.
Providence Cancer Center has ramped up its fight against oral, head and neck cancer with two new research grants totaling more than half a million dollars.
Unique to the Northwest, the new multidisciplinary clinic bridges the gap between medicine and dentistry for patients with oral, head and neck cancers.
Dr. Bryan Bell from Providence Oral, Head and Neck Cancer Clinic explains why.
Providence researchers will focus on biomarkers and vaccines to help fight the disease.
When an orthopedic surgeon told Becky Roth, a lifelong jogger, that she would never run again after cancer-related surgery on her legs, Roth told herself, "I'm going to prove him wrong."
Cancers in the throat, tongue and other areas of the head and neck are among the most common types of cancer, and treatment can be disfiguring.
R. Bryan Bell, M.D., DDS, FACS, will receive the William F. Harrigan Society Award for his contribution to oral and maxillofacial surgery.